Skip to main content
Fig. 1 | Journal of Translational Medicine

Fig. 1

From: Biofluid quantification of TWEAK/Fn14 axis in combination with a selected biomarker panel improves assessment of prostate cancer aggressiveness

Fig. 1

Spearman correlation matrix. Correlation map plotted using significance levels for Spearman test performed with relevant clinical and biomarker data from all studied patients. Positive correlations are displayed in graded blue colors and negative correlations in graded red colors. Correlations with p-value ≥ 0.05 are considered as insignificant and are left blank. Color intensity and the size of the circle are proportional to the correlation coefficients. In the right side of the correlogram, the color legend shows the correlation coefficients and the corresponding colors. BMI body mass index, HOMA-IR homeostatic model assessment for insulin resistance, HbA1c hemoglobin A1c, HDL high-density lipoprotein, LDL low-density lipoprotein, AST aspartate aminotransferase, ALT alanine aminotransferase, GGT gamma glutamyltransferase, SHBG sex hormone-binding globulin, PSA prostate-specific antigen, TWEAK tumor necrosis factor-like weak inducer of apoptosis, CD163 cluster of differentiation 163, Fn14 fibroblast growth factor-inducible 14, CXCL5 C-X-C motif chemokine 5, CCL7 chemokine (C-C motif) ligand 7, CXCR2 C-X-C motif chemokine receptor 2, CCR3 C-C chemokine receptor type 3, KLK2 kallikrenin-2 gene, KLK3 Kallikrenin-3 gene

Back to article page